Cindy Tahl's Stock Sale at Fate Therapeutics Inc

Cindy Tahl, the Chief Legal and Compliance Officer of Fate Therapeutics Inc, sold 9,037 shares of common stock on August 4, 2025, at a weighted average price of $1.0593 per share. This sale was executed to cover tax withholding obligations related to the vesting of 25,000 shares of Common Stock underlying RSUs granted to her on July 29, 2024. The sale was automatically executed pursuant to an irrevocable election by Tahl to satisfy tax withholding obligations through 'sell-to-cover' transactions and was not made at her discretion. Following this transaction, Tahl owns 397,670 shares of common stock in the company.